Literature DB >> 18820126

An intracellular loop 2 amino acid residue determines differential binding of arrestin to the dopamine D2 and D3 receptors.

Hongxiang Lan1, Martha M Teeter, Vsevolod V Gurevich, Kim A Neve.   

Abstract

Dopamine D(2) and D(3) receptors are similar subtypes with distinct interactions with arrestins; the D(3) receptor mediates less agonist-induced translocation of arrestins than the D(2) receptor. The goals of this study were to compare nonphosphorylated arrestin-binding determinants in the second intracellular domain (IC2) of the D(2) and D(3) receptors to identify residues that contribute to the differential binding of arrestin to the subtypes. Arrestin 3 bound to glutathione transferase (GST) fusion proteins of the D(2) receptor IC2 more avidly than to the D(3) receptor IC2. Mutagenesis of the fusion proteins identified a residue at the C terminus of IC2, Lys149, that was important for the preferential binding of arrestin 3 to D(2)-IC2; arrestin binding to D(2)-IC2-K149C was greatly decreased compared with wild-type D(2)-IC2, whereas binding to the reciprocal mutant D(3)-IC2-C147K was enhanced compared with wild-type D(3)-IC2. Mutating this lysine in the full-length D(2) receptor to cysteine decreased the ability of the D(2) receptor to mediate agonist-induced arrestin 3 translocation to the membrane and decreased agonist-induced receptor internalization in human embryonic kidney 293 cells. The reciprocal mutation in the D(3) receptor increased receptor-mediated translocation of arrestin 3 without affecting agonist-induced receptor internalization. G protein-coupled receptor crystal structures suggest that Lys149, at the junction of IC2 and the fourth membrane-spanning helix, has intramolecular interactions that contribute to maintaining an inactive receptor state. It is suggested that the preferential agonist-induced binding of arrestin3 to the D(2) receptor over the D(3) receptor is due in part to Lys149, which could be exposed as a result of receptor activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18820126      PMCID: PMC2606909          DOI: 10.1124/mol.108.050542

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  28 in total

1.  Characterization of the desensitization properties of five dopamine receptor subtypes and alternatively spliced variants of dopamine D2 and D4 receptors.

Authors:  Dong-Im Cho; SunRyeo Beom; Hubert H M Van Tol; Marc G Caron; Kyeong-Man Kim
Journal:  Biochem Biophys Res Commun       Date:  2006-09-26       Impact factor: 3.575

2.  High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.

Authors:  Vadim Cherezov; Daniel M Rosenbaum; Michael A Hanson; Søren G F Rasmussen; Foon Sun Thian; Tong Sun Kobilka; Hee-Jung Choi; Peter Kuhn; William I Weis; Brian K Kobilka; Raymond C Stevens
Journal:  Science       Date:  2007-10-25       Impact factor: 47.728

Review 3.  The structural basis of arrestin-mediated regulation of G-protein-coupled receptors.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Pharmacol Ther       Date:  2006-02-03       Impact factor: 12.310

4.  Structure and function of the third intracellular loop of the 5-hydroxytryptamine2A receptor: the third intracellular loop is alpha-helical and binds purified arrestins.

Authors:  E I Gelber; W K Kroeze; D L Willins; J A Gray; C A Sinar; E G Hyde; V Gurevich; J Benovic; B L Roth
Journal:  J Neurochem       Date:  1999-05       Impact factor: 5.372

5.  Dopamine D1 receptor interaction with arrestin3 in neostriatal neurons.

Authors:  Tara A Macey; Yong Liu; Vsevolod V Gurevich; Kim A Neve
Journal:  J Neurochem       Date:  2005-04       Impact factor: 5.372

6.  G protein-coupled receptor kinase regulates dopamine D3 receptor signaling by modulating the stability of a receptor-filamin-beta-arrestin complex. A case of autoreceptor regulation.

Authors:  Kyeong-Man Kim; Raul R Gainetdinov; Stephane A Laporte; Marc G Caron; Larry S Barak
Journal:  J Biol Chem       Date:  2005-02-01       Impact factor: 5.157

7.  Arrestin2 expression selectively increases during neural differentiation.

Authors:  Eugenia V Gurevich; Jeffrey L Benovic; Vsevolod V Gurevich
Journal:  J Neurochem       Date:  2004-12       Impact factor: 5.372

8.  A beta-arrestin binding determinant common to the second intracellular loops of rhodopsin family G protein-coupled receptors.

Authors:  Sébastien Marion; Robert H Oakley; Kyeong-Man Kim; Marc G Caron; Larry S Barak
Journal:  J Biol Chem       Date:  2005-11-30       Impact factor: 5.157

9.  Roles of protein kinase C and actin-binding protein 280 in the regulation of intracellular trafficking of dopamine D3 receptor.

Authors:  Eun-Young Cho; Dong-Im Cho; Jae H Park; Hitoshi Kurose; Marc G Caron; Kyeong-Man Kim
Journal:  Mol Endocrinol       Date:  2007-05-29

10.  Preferential Interaction between the dopamine D2 receptor and Arrestin2 in neostriatal neurons.

Authors:  Tara A Macey; Vsevolod V Gurevich; Kim A Neve
Journal:  Mol Pharmacol       Date:  2004-09-10       Impact factor: 4.436

View more
  14 in total

1.  Receptor conformations involved in dopamine D(2L) receptor functional selectivity induced by selected transmembrane-5 serine mutations.

Authors:  J Corey Fowler; Supriyo Bhattacharya; Jonathan D Urban; Nagarajan Vaidehi; Richard B Mailman
Journal:  Mol Pharmacol       Date:  2012-03-13       Impact factor: 4.436

2.  Alternative Splicing in Ca(V)2.2 Regulates Neuronal Trafficking via Adaptor Protein Complex-1 Adaptor Protein Motifs.

Authors:  Natsuko Macabuag; Annette C Dolphin
Journal:  J Neurosci       Date:  2015-10-28       Impact factor: 6.167

3.  β-arrestin2 plays permissive roles in the inhibitory activities of RGS9-2 on G protein-coupled receptors by maintaining RGS9-2 in the open conformation.

Authors:  Mei Zheng; Sang-Yoon Cheong; Chengchun Min; Mingli Jin; Dong-Im Cho; Kyeong-Man Kim
Journal:  Mol Cell Biol       Date:  2011-10-17       Impact factor: 4.272

4.  A dopamine D2 receptor mutant capable of G protein-mediated signaling but deficient in arrestin binding.

Authors:  Hongxiang Lan; Yong Liu; Michal I Bell; Vsevolod V Gurevich; Kim A Neve
Journal:  Mol Pharmacol       Date:  2008-09-22       Impact factor: 4.436

5.  Phosphorylation barcode-dependent signal bias of the dopamine D1 receptor.

Authors:  Ali I Kaya; Nicole A Perry; Vsevolod V Gurevich; T M Iverson
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-05       Impact factor: 11.205

Review 6.  β-Arrestin-mediated receptor trafficking and signal transduction.

Authors:  Sudha K Shenoy; Robert J Lefkowitz
Journal:  Trends Pharmacol Sci       Date:  2011-06-15       Impact factor: 14.819

Review 7.  New Concepts in Dopamine D2 Receptor Biased Signaling and Implications for Schizophrenia Therapy.

Authors:  Nikhil M Urs; Sean M Peterson; Marc G Caron
Journal:  Biol Psychiatry       Date:  2016-10-19       Impact factor: 13.382

8.  Regulation of membrane cholecystokinin-2 receptor by agonists enables classification of partial agonists as biased agonists.

Authors:  Rémi Magnan; Bernard Masri; Chantal Escrieut; Magali Foucaud; Pierre Cordelier; Daniel Fourmy
Journal:  J Biol Chem       Date:  2010-12-14       Impact factor: 5.157

9.  G protein-coupled receptor kinase-mediated phosphorylation regulates post-endocytic trafficking of the D2 dopamine receptor.

Authors:  Yoon Namkung; Concetta Dipace; Jonathan A Javitch; David R Sibley
Journal:  J Biol Chem       Date:  2009-03-30       Impact factor: 5.157

10.  Role of Beta-arrestin 2 downstream of dopamine receptors in the Basal Ganglia.

Authors:  Thomas Del'guidice; Morgane Lemasson; Jean-Martin Beaulieu
Journal:  Front Neuroanat       Date:  2011-09-06       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.